LMR Partners’s Zomedica Corp. ZOM Stock Holding History

LMR Partners’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-47,495	Closed	-$18K	–	618
2019 Q3	$18K	Hold	47,495	–	–	﹤0.01%	402
2019 Q2	$11K	Buy	+47,495	New	+$14.4K	﹤0.01%	414

Other funds holding ZOM

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

JVL Associates Wyoming, Michigan $352M AUM 27.55% 1-Year Est. Return

RIS

Retirement Income Solutions Ann Arbor, Michigan $585M AUM 15.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

LMR Partners's ZOM Position: Q4 2019 in Review

LMR Partners sold out of Zomedica Corp. (ZOM) in Q4 2019, closing a stake of 47,495 shares — an estimated $18K sold.

LMR Partners first reported a position in ZOM in Q2 2019 and held it in 2 quarters. The position peaked at $18K in Q3 2019. 21 funds tracked by Wall St. Rank hold ZOM as of Q4 2019.

LMR Partners reported no remaining Zomedica Corp. position as of Q4 2019 after selling out during the quarter.
LMR Partners sold 47,495 Zomedica Corp. shares in Q4 2019, an estimated $18K.
LMR Partners first reported a position in Zomedica Corp. in Q2 2019 and held it in 2 quarters.
LMR Partners's Zomedica Corp. position peaked at $18K in Q3 2019.
21 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2019.

Based on LMR Partners's 13F filing for Q4 2019, filed 14 Feb 2020.